These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 17974748

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
    Findling RL, Wigal SB, Bukstein OG, Boellner SW, Abikoff HB, Turnbow JM, Civil R.
    Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
    [Abstract] [Full Text] [Related]

  • 5. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
    Brams M, Mao AR, Doyle RL.
    Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
    [Abstract] [Full Text] [Related]

  • 6. Adderall XR: long acting stimulant for single daily dosing.
    Sallee FR, Smirnoff AV.
    Expert Rev Neurother; 2004 Nov; 4(6):927-34. PubMed ID: 15853519
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting.
    Warshaw EM, Paller AS, Fowler JF, Zirwas MJ.
    Clin Ther; 2008 Feb; 30(2):326-37. PubMed ID: 18343271
    [Abstract] [Full Text] [Related]

  • 10. Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder.
    Elia J, Wilson Z, La Porta LS, Algon SA, Prowler ML, Cartwright ST, McKenna PA, Laracy S, Takeda T, Borgmann-Winter K.
    Expert Rev Clin Pharmacol; 2011 May; 4(3):311-28. PubMed ID: 22114778
    [Abstract] [Full Text] [Related]

  • 11. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
    Findling RL.
    Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
    [Abstract] [Full Text] [Related]

  • 12. Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder.
    McGough JJ, Pataki CS, Suddath R.
    Expert Rev Neurother; 2005 Jul; 5(4):437-41. PubMed ID: 16026226
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Advances in psychotropic formulations.
    Keith S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):996-1008. PubMed ID: 16678954
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stimulant medication and short attention span: a clinical approach.
    Davy T, Rodgers CL.
    J Dev Behav Pediatr; 1989 Dec 30; 10(6):313-8. PubMed ID: 2513337
    [Abstract] [Full Text] [Related]

  • 20. Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.
    Capp PK, Pearl PL, Conlon C.
    Expert Rev Neurother; 2005 May 30; 5(3):325-31. PubMed ID: 15938665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.